vs
Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and AGIOS PHARMACEUTICALS, INC. (AGIO). Click either name above to swap in a different company.
ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $20.0M, roughly 1.2× AGIOS PHARMACEUTICALS, INC.). On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 36.4%). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 13.7%).
ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
ADCT vs AGIO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.1M | $20.0M |
| Net Profit | — | $-108.0M |
| Gross Margin | — | 90.6% |
| Operating Margin | -77.7% | -608.9% |
| Net Margin | — | -541.1% |
| Revenue YoY | 36.4% | 86.1% |
| Net Profit YoY | — | -11.9% |
| EPS (diluted) | $0.04 | $-1.86 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.1M | $20.0M | ||
| Q3 25 | $15.8M | $12.9M | ||
| Q2 25 | $18.1M | $12.5M | ||
| Q1 25 | $17.4M | $8.7M | ||
| Q4 24 | $16.9M | $10.7M | ||
| Q3 24 | $18.0M | $9.0M | ||
| Q2 24 | $17.0M | $8.6M | ||
| Q1 24 | $17.8M | $8.2M |
| Q4 25 | — | $-108.0M | ||
| Q3 25 | $-41.0M | $-103.4M | ||
| Q2 25 | $-56.6M | $-112.0M | ||
| Q1 25 | $-38.6M | $-89.3M | ||
| Q4 24 | — | $-96.5M | ||
| Q3 24 | $-44.0M | $947.9M | ||
| Q2 24 | $-36.5M | $-96.1M | ||
| Q1 24 | $-46.6M | $-81.5M |
| Q4 25 | — | 90.6% | ||
| Q3 25 | — | 87.0% | ||
| Q2 25 | — | 86.3% | ||
| Q1 25 | — | 87.6% | ||
| Q4 24 | — | 88.3% | ||
| Q3 24 | — | 91.3% | ||
| Q2 24 | — | 82.6% | ||
| Q1 24 | — | 92.3% |
| Q4 25 | -77.7% | -608.9% | ||
| Q3 25 | -196.6% | -907.4% | ||
| Q2 25 | -244.1% | -1020.1% | ||
| Q1 25 | -163.5% | -1222.0% | ||
| Q4 24 | -191.8% | -1165.3% | ||
| Q3 24 | -197.4% | -1146.9% | ||
| Q2 24 | -170.5% | -1228.3% | ||
| Q1 24 | -188.3% | -1124.3% |
| Q4 25 | — | -541.1% | ||
| Q3 25 | -260.1% | -803.1% | ||
| Q2 25 | -313.2% | -899.4% | ||
| Q1 25 | -221.8% | -1023.3% | ||
| Q4 24 | — | -899.6% | ||
| Q3 24 | -244.1% | 10574.7% | ||
| Q2 24 | -214.6% | -1115.7% | ||
| Q1 24 | -261.1% | -995.8% |
| Q4 25 | $0.04 | $-1.86 | ||
| Q3 25 | $-0.30 | $-1.78 | ||
| Q2 25 | $-0.50 | $-1.93 | ||
| Q1 25 | $-0.36 | $-1.55 | ||
| Q4 24 | $-0.26 | $-1.44 | ||
| Q3 24 | $-0.42 | $16.22 | ||
| Q2 24 | $-0.38 | $-1.69 | ||
| Q1 24 | $-0.56 | $-1.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $261.3M | $89.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-185.8M | $1.2B |
| Total Assets | $323.1M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $261.3M | $89.1M | ||
| Q3 25 | $234.7M | $92.7M | ||
| Q2 25 | $264.6M | $80.9M | ||
| Q1 25 | $194.7M | $79.0M | ||
| Q4 24 | $250.9M | $76.2M | ||
| Q3 24 | $274.3M | $253.7M | ||
| Q2 24 | $300.1M | $84.5M | ||
| Q1 24 | $234.3M | $118.8M |
| Q4 25 | $-185.8M | $1.2B | ||
| Q3 25 | $-238.2M | $1.3B | ||
| Q2 25 | $-199.2M | $1.4B | ||
| Q1 25 | $-238.2M | $1.5B | ||
| Q4 24 | $-202.6M | $1.5B | ||
| Q3 24 | $-171.9M | $1.6B | ||
| Q2 24 | $-131.7M | $660.5M | ||
| Q1 24 | $-194.4M | $743.9M |
| Q4 25 | $323.1M | $1.3B | ||
| Q3 25 | $289.8M | $1.4B | ||
| Q2 25 | $321.6M | $1.5B | ||
| Q1 25 | $272.5M | $1.6B | ||
| Q4 24 | $322.0M | $1.7B | ||
| Q3 24 | $349.1M | $1.8B | ||
| Q2 24 | $371.8M | $773.1M | ||
| Q1 24 | $308.0M | $849.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-31.1M | $-96.2M |
| Free Cash FlowOCF − Capex | — | $-97.3M |
| FCF MarginFCF / Revenue | — | -487.5% |
| Capex IntensityCapex / Revenue | 0.0% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-377.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-31.1M | $-96.2M | ||
| Q3 25 | $-29.6M | $-88.2M | ||
| Q2 25 | $-24.1M | $-77.1M | ||
| Q1 25 | $-56.3M | $-111.5M | ||
| Q4 24 | $-21.9M | $-133.2M | ||
| Q3 24 | $-25.0M | $-84.2M | ||
| Q2 24 | $-32.8M | $-72.6M | ||
| Q1 24 | $-44.1M | $-99.9M |
| Q4 25 | — | $-97.3M | ||
| Q3 25 | — | $-89.7M | ||
| Q2 25 | — | $-78.0M | ||
| Q1 25 | $-56.6M | $-112.3M | ||
| Q4 24 | $-21.9M | $-134.1M | ||
| Q3 24 | $-25.3M | $-84.6M | ||
| Q2 24 | $-32.9M | $-72.7M | ||
| Q1 24 | $-44.6M | $-100.0M |
| Q4 25 | — | -487.5% | ||
| Q3 25 | — | -696.5% | ||
| Q2 25 | — | -626.2% | ||
| Q1 25 | -325.2% | -1286.4% | ||
| Q4 24 | -129.8% | -1250.1% | ||
| Q3 24 | -140.2% | -944.2% | ||
| Q2 24 | -193.0% | -844.4% | ||
| Q1 24 | -250.0% | -1221.2% |
| Q4 25 | 0.0% | 5.6% | ||
| Q3 25 | 0.0% | 12.1% | ||
| Q2 25 | 0.0% | 7.0% | ||
| Q1 25 | 1.5% | 8.8% | ||
| Q4 24 | 0.5% | 9.0% | ||
| Q3 24 | 1.2% | 4.7% | ||
| Q2 24 | 0.2% | 1.8% | ||
| Q1 24 | 3.0% | 1.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.09× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
